Wiley Matthew T.
Reporting owner on Forms 3, 4 and 5, CIK 1759703.
Wiley Matthew T. reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-09-29.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Definium Therapeutics, Inc. CIK 1813814 | officer (Chief Commercial Officer) | 1 | 2026-09-29 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Definium Therapeutics, Inc. Common Shares | 2026-09-25 | S sold | -3,097 | $36.57 | 359,036 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001104659-26-112061 | Definium Therapeutics, Inc. | 2026-09-29 |